Similar articles

• Mixed cryoglobulinaemia and hepatitis C virus infection.

  Grandinetti F, De Paola L, Prunesti P, Mazzitello G. Grandinetti F, et al. Ital J Gastroenterol Hepatol. 1997 Dec;29(6):579. Ital J Gastroenterol Hepatol. 1997. PMID: 9513839 No abstract available.
• Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia.

  Di Lullo L, De Rosa FG, Coviello R, Sorgi ML, Coen G, Zorzin LR, Casato M. Di Lullo L, et al. Clin Exp Rheumatol. 1998 Jul-Aug;16(4):506. Clin Exp Rheumatol. 1998. PMID: 9706438 No abstract available.
• Treatment of hepatitis C-virus-related glomerulonephritis.

  Kamar N, Rostaing L, Alric L. Kamar N, et al. Kidney Int. 2006 Feb;69(3):436-9. doi: 10.1038/sj.ki.5000142. Kidney Int. 2006. PMID: 16514428 Review.
• Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection.

  Rosas SE, Tomaszewski JE, Feldman HI, Foster MH. Rosas SE, et al. Am J Nephrol. 1999;19(5):599-604. doi: 10.1159/000013527. Am J Nephrol. 1999. PMID: 10575191
• Cryoglobulinemia and renal disease.

  Alpers CE, Smith KD. Alpers CE, et al. Curr Opin Nephrol Hypertens. 2008 May;17(3):243-9. doi: 10.1097/MNH.0b013e3282f8afe2. Curr Opin Nephrol Hypertens. 2008. PMID: 18408474 Review.